
    
      The purpose of this study is to observe predictors of pituitary tumor recurrence and markers
      of persistent disease activity through computerized collection of comprehensive demographic,
      therapeutic, pathologic and outcome information on patients harboring pituitary mass lesions
      of all types.
    
  